Pediatrics:GERD疾病标签或致婴儿过度治疗

2013-04-18 Pediatrics 中国医学论坛报

    美国一项研究表明,胃食管反流病(GERD)标签可能导致父母对婴儿进行过度药物治疗。论文4月1日在线发表于《儿科学》(Pediatrics)。   该研究利用2 × 2析因设计对婴儿父母进行了临床场景模拟评估。即便被告知药物可能无效,被诊断GERD婴儿的父母仍倾向于对孩子进行药物治疗。而未被诊断GERD婴儿父母则仅在药物可能有效的情况下,接受药物治疗。  

GERD疾病标签或致婴儿过度治疗
 

  美国一项研究表明,胃食管反流病(GERD)标签可能导致父母对婴儿进行过度药物治疗。论文4月1日在线发表于《儿科学》(Pediatrics)。

  该研究利用2 × 2析因设计对婴儿父母进行了临床场景模拟评估。即便被告知药物可能无效,被诊断GERD婴儿的父母仍倾向于对孩子进行药物治疗。而未被诊断GERD婴儿父母则仅在药物可能有效的情况下,接受药物治疗。

  研究者指出, 作为医师,我们必须重视与患者家属交谈时的用辞,因为患儿父母可能将正常的过程认为是疾病。作为儿科医师,我们的工作是让患儿恢复健康,而不是让健康的婴儿患病,不必要的药物治疗,可能增加患儿肺炎发生率。

GERD相关的拓展阅读:


Prognostic Values of Multichannel Intraluminal Impedance and pH Monitoring in Newborns with Symptoms of Gastroesophageal Reflux Disease
Objective
To evaluate the relationship between multichannel intraluminal impedance and pH monitoring (MII/pH) values in newborns with symptoms of gastroesophageal reflux disease (GERD) and clinical history in their first 3 years of life.
Study design
Sixty-four newborns with GERD symptoms who underwent MII/pH in the first weeks of life were enrolled into a clinical follow-up program. Follow-up visits were programmed at 1, 3, 6, 9, 12, 18, 24, and 36 months. Patients were divided into 3 groups according to duration of symptoms: short (1-3 months), medium (4-9 months), and long (>9 months), and MII/pH values in these groups were compared.
Results
Fifty-three patients completed the 3-year follow-up. The number of patients with GERD symptoms decreased each month. A comparison of MII/pH values of the 3 lifetime symptom groups revealed differences in the impedance bolus exposure index (F = 83; P = .012) and proximal reflux frequency (F = 410; P = .022). These 2 MII variables showed an increasing trend from the short lifetime symptom group to the long lifetime symptom group. Weakly acidic reflux events, but not acidic events, were responsible for these differences.
Conclusion
MII/pH in newborns has prognostic value regarding the duration of GERD symptoms and provides useful information that clinicians may give parents about the prognosis of symptomatic infants. Impedance bolus exposure index and proximal reflux frequency seem to be the variables with the highest predictive value. Weakly acidic reflux events play an important role in determining the duration of GERD symptoms in newborns.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2021462, encodeId=2c4f202146220, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Nov 18 01:20:00 CST 2013, time=2013-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745083, encodeId=91371e45083a2, content=<a href='/topic/show?id=321a940118c' target=_blank style='color:#2F92EE;'>#过度治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94011, encryptionId=321a940118c, topicName=过度治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e6435510490, createdName=jxrzshh, createdTime=Sat Aug 17 20:20:00 CST 2013, time=2013-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725493, encodeId=edae1e25493a1, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Jan 22 11:20:00 CST 2014, time=2014-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958371, encodeId=c13319583e1ac, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Aug 03 12:20:00 CST 2013, time=2013-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636647, encodeId=bde8163664e67, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Dec 23 18:20:00 CST 2013, time=2013-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471835, encodeId=6e7714e1835df, content=<a href='/topic/show?id=4ff9e967c4' target=_blank style='color:#2F92EE;'>#GERD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7967, encryptionId=4ff9e967c4, topicName=GERD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=929a7169504, createdName=mashirong, createdTime=Sat Apr 20 00:20:00 CST 2013, time=2013-04-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2021462, encodeId=2c4f202146220, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Nov 18 01:20:00 CST 2013, time=2013-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745083, encodeId=91371e45083a2, content=<a href='/topic/show?id=321a940118c' target=_blank style='color:#2F92EE;'>#过度治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94011, encryptionId=321a940118c, topicName=过度治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e6435510490, createdName=jxrzshh, createdTime=Sat Aug 17 20:20:00 CST 2013, time=2013-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725493, encodeId=edae1e25493a1, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Jan 22 11:20:00 CST 2014, time=2014-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958371, encodeId=c13319583e1ac, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Aug 03 12:20:00 CST 2013, time=2013-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636647, encodeId=bde8163664e67, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Dec 23 18:20:00 CST 2013, time=2013-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471835, encodeId=6e7714e1835df, content=<a href='/topic/show?id=4ff9e967c4' target=_blank style='color:#2F92EE;'>#GERD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7967, encryptionId=4ff9e967c4, topicName=GERD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=929a7169504, createdName=mashirong, createdTime=Sat Apr 20 00:20:00 CST 2013, time=2013-04-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2021462, encodeId=2c4f202146220, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Nov 18 01:20:00 CST 2013, time=2013-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745083, encodeId=91371e45083a2, content=<a href='/topic/show?id=321a940118c' target=_blank style='color:#2F92EE;'>#过度治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94011, encryptionId=321a940118c, topicName=过度治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e6435510490, createdName=jxrzshh, createdTime=Sat Aug 17 20:20:00 CST 2013, time=2013-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725493, encodeId=edae1e25493a1, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Jan 22 11:20:00 CST 2014, time=2014-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958371, encodeId=c13319583e1ac, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Aug 03 12:20:00 CST 2013, time=2013-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636647, encodeId=bde8163664e67, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Dec 23 18:20:00 CST 2013, time=2013-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471835, encodeId=6e7714e1835df, content=<a href='/topic/show?id=4ff9e967c4' target=_blank style='color:#2F92EE;'>#GERD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7967, encryptionId=4ff9e967c4, topicName=GERD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=929a7169504, createdName=mashirong, createdTime=Sat Apr 20 00:20:00 CST 2013, time=2013-04-20, status=1, ipAttribution=)]
    2014-01-22 feather89
  4. [GetPortalCommentsPageByObjectIdResponse(id=2021462, encodeId=2c4f202146220, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Nov 18 01:20:00 CST 2013, time=2013-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745083, encodeId=91371e45083a2, content=<a href='/topic/show?id=321a940118c' target=_blank style='color:#2F92EE;'>#过度治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94011, encryptionId=321a940118c, topicName=过度治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e6435510490, createdName=jxrzshh, createdTime=Sat Aug 17 20:20:00 CST 2013, time=2013-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725493, encodeId=edae1e25493a1, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Jan 22 11:20:00 CST 2014, time=2014-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958371, encodeId=c13319583e1ac, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Aug 03 12:20:00 CST 2013, time=2013-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636647, encodeId=bde8163664e67, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Dec 23 18:20:00 CST 2013, time=2013-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471835, encodeId=6e7714e1835df, content=<a href='/topic/show?id=4ff9e967c4' target=_blank style='color:#2F92EE;'>#GERD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7967, encryptionId=4ff9e967c4, topicName=GERD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=929a7169504, createdName=mashirong, createdTime=Sat Apr 20 00:20:00 CST 2013, time=2013-04-20, status=1, ipAttribution=)]
    2013-08-03 hbwxf
  5. [GetPortalCommentsPageByObjectIdResponse(id=2021462, encodeId=2c4f202146220, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Nov 18 01:20:00 CST 2013, time=2013-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745083, encodeId=91371e45083a2, content=<a href='/topic/show?id=321a940118c' target=_blank style='color:#2F92EE;'>#过度治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94011, encryptionId=321a940118c, topicName=过度治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e6435510490, createdName=jxrzshh, createdTime=Sat Aug 17 20:20:00 CST 2013, time=2013-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725493, encodeId=edae1e25493a1, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Jan 22 11:20:00 CST 2014, time=2014-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958371, encodeId=c13319583e1ac, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Aug 03 12:20:00 CST 2013, time=2013-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636647, encodeId=bde8163664e67, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Dec 23 18:20:00 CST 2013, time=2013-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471835, encodeId=6e7714e1835df, content=<a href='/topic/show?id=4ff9e967c4' target=_blank style='color:#2F92EE;'>#GERD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7967, encryptionId=4ff9e967c4, topicName=GERD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=929a7169504, createdName=mashirong, createdTime=Sat Apr 20 00:20:00 CST 2013, time=2013-04-20, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2021462, encodeId=2c4f202146220, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Nov 18 01:20:00 CST 2013, time=2013-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745083, encodeId=91371e45083a2, content=<a href='/topic/show?id=321a940118c' target=_blank style='color:#2F92EE;'>#过度治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94011, encryptionId=321a940118c, topicName=过度治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e6435510490, createdName=jxrzshh, createdTime=Sat Aug 17 20:20:00 CST 2013, time=2013-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725493, encodeId=edae1e25493a1, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Jan 22 11:20:00 CST 2014, time=2014-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958371, encodeId=c13319583e1ac, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Aug 03 12:20:00 CST 2013, time=2013-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636647, encodeId=bde8163664e67, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Dec 23 18:20:00 CST 2013, time=2013-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471835, encodeId=6e7714e1835df, content=<a href='/topic/show?id=4ff9e967c4' target=_blank style='color:#2F92EE;'>#GERD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7967, encryptionId=4ff9e967c4, topicName=GERD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=929a7169504, createdName=mashirong, createdTime=Sat Apr 20 00:20:00 CST 2013, time=2013-04-20, status=1, ipAttribution=)]
    2013-04-20 mashirong

相关资讯

J. Pediatr:牛奶激发试验或有助确诊过敏患儿的GERD

近日,国际期刊《儿科学杂志》(The Journal of Pediatrics)在线发表的一项研究显示,一些牛奶过敏患儿可能合并胃食管反流病(GERD),而牛奶激发试验可能有助于诊断后者。 主要研究者、英国伦敦大奥蒙德街病童医院的Osvaldo Borrelli博士及其同事,对17例已确诊CMA且怀疑GERD的儿童进行了研究。研究者对受试儿童置入了多波段腔内阻抗-pH值监测器,连续监测48 h